SCHEMBL5753349

SCHEMBL5753349

CCOC(=O)C(Cc1ccc(OC(F)(F)F)cc1)C(=O)c1ccc(F)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 8/20 0.54
PPARG P37231 6/20 0.54
PPARA Q07869 2/20 0.54
POLB P06746 1/20 0.43
USP30 Q70CQ3 1/20 0.43
ACACB O00763 1/20 0.41
NR1H4 Q96RI1 1/20 0.41
MDM2 Q00987 1/20 0.41
TP53 P04637 1/20 0.40
HPGD P15428 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
MEN1 O00255 1/20 0.40
MAPT P10636 1/20 0.40
CASP3 P42574 1/20 0.40
KMT2A Q03164 1/20 0.40
TRPV1 Q8NER1 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
MMP8 P22894 1/20 0.40
CASR P41180 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5754407 0.91 PPARG (0.45) EPHX2PPARGPPARAUSP30MDM2
SCHEMBL5748807 0.89 EPHX2 (0.54) EPHX2PPARGMDM2HPGDMEN1
SCHEMBL5752926 0.86 LDHA (0.52) EPHX2PPARGPPARAMDM2HPGD
SCHEMBL5753584 0.86 MDM2 (0.49) EPHX2PPARGPPARAMDM2MEN1
SCHEMBL16633434 0.86 EPHX2 (0.58) EPHX2PPARGPPARAPOLBACACB
SCHEMBL5751165 0.85 PPARG (0.54) EPHX2PPARGPPARAMDM2MAPT
SCHEMBL5751205 0.85 PPARG (0.54) EPHX2PPARGPPARAMDM2MAPT
SCHEMBL5750744 0.84 EPHX2 (0.49) EPHX2PPARGPPARAMDM2MEN1
SCHEMBL5750573 0.83 PPARG (0.53) EPHX2PPARGPPARAMDM2HPGD
SCHEMBL5752445 0.83 EPHX2 (0.50) EPHX2PPARGPPARANR1H4MDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6982348-B2 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-01-03 US disclosed
US-20040127574-A1 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-07-01 US disclosed
EP-1362846-A1 AMINOETHANOL DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-11-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040127574-A1 Aminoethanol derivatives CETP, LCAT, MTTP EPHX2 1434/4885PPARG 905/4885PPARA 708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.